SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-013154
Filing Date
2020-11-06
Accepted
2020-11-06 16:08:30
Documents
73
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q nviv-20200930x10q.htm 10-Q 1174941
2 EX-31.1 nviv-20200930ex311a9866b.htm EX-31.1 14055
3 EX-31.2 nviv-20200930ex3125f1ec0.htm EX-31.2 13763
4 EX-32.1 nviv-20200930ex321cfa2df.htm EX-32.1 7579
5 EX-32.2 nviv-20200930ex32250bcdb.htm EX-32.2 7640
  Complete submission text file 0001558370-20-013154.txt   6057074

Data Files

Seq Description Document Type Size
6 EX-101.INS nviv-20200930.xml EX-101.INS 1315201
7 EX-101.SCH nviv-20200930.xsd EX-101.SCH 48608
8 EX-101.CAL nviv-20200930_cal.xml EX-101.CAL 43702
9 EX-101.DEF nviv-20200930_def.xml EX-101.DEF 186257
10 EX-101.LAB nviv-20200930_lab.xml EX-101.LAB 446293
11 EX-101.PRE nviv-20200930_pre.xml EX-101.PRE 348486
Mailing Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139 617-863-5524
INVIVO THERAPEUTICS HOLDINGS CORP. (Filer) CIK: 0001292519 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37350 | Film No.: 201294477
SIC: 3841 Surgical & Medical Instruments & Apparatus